8-K: Novo Integrated Sciences Secures $6.21 Million Loan, Repays Existing Debt

Novo Integrated Sciences has secured a $6.21 million loan from Streeterville Capital, using a portion of the funds to repay existing debt.

Summary

• Novo Integrated Sciences secured a $6.21 million loan from Streeterville Capital, structured as a secured convertible promissory note.
• The loan has a maturity date of April 8, 2025, and carries an interest rate of 10.9% per annum.
• The company received $5.5 million in net proceeds after an original issue discount of $660,000 and $50,000 for transaction costs.
• Novo used the loan proceeds to fully repay two existing promissory notes totaling $3,777,777.77.
• The note can be converted into common stock if the intraday trade price is 10% greater than the previous day's closing price, at a conversion price equal to 85% of the lowest daily volume weighted average price during the five trading days prior to conversion.
• Starting October 8, 2024, the lender can redeem up to $950,000 of the note per month, payable in cash or, under certain conditions, in shares of common stock.
• The company can prepay the note at 105% of the outstanding balance before an event of default occurs.
• The note includes events of default, which, if triggered, would result in the outstanding balance plus a 5% or 20% trigger effect becoming immediately due and payable.
• The total number of shares issued under the agreement is capped at 19.99% of the outstanding common stock unless shareholder approval is obtained.
• The company must seek shareholder approval within 6 months and repay the note in cash if approval is not obtained within 9 months.
• The loan is secured by a security interest in all of the company's assets and is guaranteed by two of its subsidiaries, Acenzia Inc. and Novo Healthnet Limited.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While securing the loan and repaying existing debt are positive, the high interest rate, original issue discount, and potential dilution through conversion are concerning. The monthly redemption option for the lender also adds a layer of risk.

Positives

• The company has secured a significant loan of $6.21 million.
• The company has successfully repaid $3,777,777.77 in existing debt, reducing its financial obligations.
• The loan includes a conversion option, which could be beneficial for the company if the stock price increases.
• The company has the option to prepay the loan, providing flexibility in managing its debt.
• The company has addressed concerns about dilution by repaying the Mast Hill and FirstFire notes with cash.

Negatives

• The loan includes a significant original issue discount of $660,000 and $50,000 in transaction costs, reducing the net proceeds.
• The loan carries a relatively high interest rate of 10.9% per annum.
• The lender has the option to redeem up to $950,000 of the note monthly, which could put pressure on the company's cash flow.
• The company is required to seek shareholder approval for the potential issuance of shares exceeding 19.99% of the outstanding common stock.
• Failure to obtain shareholder approval within 9 months will require the company to repay the note in cash.
• The loan is secured by all company assets, which could be a risk if the company defaults.

Risks

• The company is obligated to seek shareholder approval for the potential issuance of shares exceeding 19.99% of the outstanding common stock, and failure to obtain this approval within 9 months will require the company to repay the note in cash.
• The lender has the option to redeem up to $950,000 of the note monthly, which could put pressure on the company's cash flow.
• The loan is secured by all company assets, which could be a risk if the company defaults.
• The note includes events of default that could trigger immediate repayment of the outstanding balance plus a 5% or 20% trigger effect.
• The conversion of the note into common stock could lead to dilution of existing shareholders if the stock price increases.

Future Outlook

The company is working towards closing other transactions to raise non-dilutive funding, but the company has not provided specific guidance on future financial performance.

Management Comments

• Robert Mattacchione, the company's CEO and Board Chairman, stated that repaying the Mast Hill and FirstFire notes with cash is very important to curtail dilution.
• The CEO also mentioned the company is working towards closing other transactions to raise non-dilutive funding.

Industry Context

This announcement reflects a common practice of companies seeking financing through convertible debt instruments. The use of a security interest and guarantees from subsidiaries is also a standard practice to protect the lender's investment. The repayment of existing debt suggests a move to clean up the balance sheet and reduce dilution.

Comparison to Industry Standards

• The interest rate of 10.9% is relatively high, which may indicate a higher risk profile for Novo Integrated Sciences compared to companies with lower borrowing costs.
• The conversion feature is a common element in financing agreements for growth companies, allowing the lender to benefit from potential stock appreciation.
• The monthly redemption option for the lender is not standard and may indicate a higher risk profile for the company.
• The requirement for shareholder approval to issue more than 19.99% of the outstanding shares is a standard protection for existing shareholders.
• The security interest in all company assets and guarantees from subsidiaries are typical for secured loans, providing the lender with recourse in case of default.
• The terms of the loan are similar to other small cap companies seeking funding, but the high interest rate and monthly redemption option are less common.

Stakeholder Impact

• Shareholders may experience dilution if the note is converted into common stock.
• Employees may be impacted by the company's financial performance and ability to meet its obligations.
• Customers may be impacted by the company's ability to continue providing services and products.
• Suppliers may be impacted by the company's ability to pay its bills.
• Creditors may be impacted by the company's ability to repay its debts.

Next Steps

• The company needs to seek shareholder approval for the potential issuance of shares exceeding 19.99% of the outstanding common stock within 6 months.
• The company needs to manage its cash flow to meet the potential monthly redemption requests from the lender.
• The company needs to file a registration statement covering the Holders resale of the Common Stock underlying the Note within 75 days of the closing date.

Key Dates

Keywords

convertible promissory note, secured loan, Streeterville Capital, debt repayment, shareholder approval, security interest, Acenzia Inc., Novo Healthnet Limited, conversion price, redemption, original issue discount